天龍集團(300063.SZ)擬收購睿道科技100%股權 11月27日起停牌
格隆匯11月26日丨天龍集團(300063.SZ)公佈,公司擬以發行股份及支付現金方式購買張耀宏、鎮江睿覽企業管理諮詢中心(有限合夥)(“鎮江睿覽”)、平潭立湧股權投資合夥企業(有限合夥)(“平潭立湧”)、鎮江睿渥企業管理諮詢中心(有限合夥)(“鎮江睿渥”)、鎮江睿姿企業管理諮詢中心(有限合夥)(“鎮江睿姿”)合計持有的北京睿道網絡科技有限公司(“睿道科技”或“標的公司”)100%股權,並向不超過5名特定投資者非公開發行股份募集配套資金。
公司股票自2019年11月27日上午開市起停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.